Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

NCT05546853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: NP137
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Calcium levofolinate
DRUG: 5 FU

Sponsor

University Hospital, Grenoble

Collaborators

[object Object]